Aromatase inhibitors (AI) treat some breast cancers that depend on estrogen levels by blocking the enzyme aromatase, which converts androgens into estrogen in the body (Mamounas et al., 2019). The gene discussed is CYP19A1; the disease is breast carcinoma.